Request Demo
Last update 27 Jun 2025
Shanghai Yuyao Biotechnology Co., Ltd.
Private Company | Subsidiary Company|2020|Shanghai Shi, China
Private Company | Subsidiary Company|2020|Shanghai Shi, China
Last update 27 Jun 2025
Overview
Basic Info
Introduction Shanghai Yuyao Biotechnology Co., Ltd. was established in April 13, 2020, Their main business includes technology services, technology consulting, technology transfers, and technology promotions. They focus on utilizing artificial intelligence and modern new drug creation technologies to address significant clinical drug needs, and are committed to enhancing human health levels. The company also established close cooperative relationships with top domestic institutions and research organizations, collectively promoting the integration of production, education, and research. |
Tags
Neoplasms
Hemic and Lymphatic Diseases
Digestive System Disorders
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
NCT06228846
An Open-Label Phase I Study to Evaluate the Safety,Tolerability and Preliminary Efficacy of YY001 in Patients with Advanced Solid Tumors
100 Clinical Results associated with Shanghai Yuyao Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Yuyao Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Yuyao Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 29 Jun 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
4
Preclinical
Phase 1
1
1
Phase 2
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free